506 related articles for article (PubMed ID: 30052813)
21. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
[TBL] [Abstract][Full Text] [Related]
22. The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study.
Zak-Doron Y; Dishon Benattar Y; Pfeffer I; Daikos GL; Skiada A; Antoniadou A; Durante-Mangoni E; Andini R; Cavezza G; Leibovici L; Yahav D; Eliakim-Raz N; Carmeli Y; Nutman A; Paul M;
Clin Infect Dis; 2018 Nov; 67(12):1815-1823. PubMed ID: 29718143
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals.
Papst L; Beović B; Pulcini C; Durante-Mangoni E; Rodríguez-Baño J; Kaye KS; Daikos GL; Raka L; Paul M;
Clin Microbiol Infect; 2018 Oct; 24(10):1070-1076. PubMed ID: 29410094
[TBL] [Abstract][Full Text] [Related]
24. Attributable mortality from extensively drug-resistant gram-negative infections using propensity-matched tracer antibiotic algorithms.
Kadri SS; Strich JR; Swihart BJ; Hohmann S; Dekker JP; Palmore T; Bonne S; Freeman B; Raybould J; Shah NG; Patel D; Husson J; Jacobs MD; Duong L; Follmann D; Hooper DC; Timpone J; Danner RL
Am J Infect Control; 2019 Sep; 47(9):1040-1047. PubMed ID: 30824387
[TBL] [Abstract][Full Text] [Related]
25. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Micek ST; Welch EC; Khan J; Pervez M; Doherty JA; Reichley RM; Kollef MH
Antimicrob Agents Chemother; 2010 May; 54(5):1742-8. PubMed ID: 20160050
[TBL] [Abstract][Full Text] [Related]
26. Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome.
Ozsurekci Y; Aykac K; Cengiz AB; Basaranoglu ST; Sancak B; Karahan S; Kara A; Ceyhan M
Diagn Microbiol Infect Dis; 2017 Apr; 87(4):359-364. PubMed ID: 28089138
[TBL] [Abstract][Full Text] [Related]
27. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
[TBL] [Abstract][Full Text] [Related]
28. An update on the management of urinary tract infections in the era of antimicrobial resistance.
Bader MS; Loeb M; Brooks AA
Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
[TBL] [Abstract][Full Text] [Related]
29. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
[TBL] [Abstract][Full Text] [Related]
30. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
31. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
Righi E; Mutters NT; Guirao X; Del Toro MD; Eckmann C; Friedrich AW; Giannella M; Kluytmans J; Presterl E; Christaki E; Cross ELA; Visentin A; Sganga G; Tsioutis C; Tacconelli E
Clin Microbiol Infect; 2023 Apr; 29(4):463-479. PubMed ID: 36566836
[TBL] [Abstract][Full Text] [Related]
32. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
[TBL] [Abstract][Full Text] [Related]
33. Severe infections caused by difficult-to-treat Gram-negative bacteria.
Dettori S; Portunato F; Vena A; Giacobbe DR; Bassetti M
Curr Opin Crit Care; 2023 Oct; 29(5):438-445. PubMed ID: 37641512
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy.
Crusio R; Rao S; Changawala N; Paul V; Tiu C; van Ginkel J; Chapnick E; Kupfer Y
Scand J Infect Dis; 2014 Jan; 46(1):1-8. PubMed ID: 24206450
[TBL] [Abstract][Full Text] [Related]
35. The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease.
Ferstl PG; Filmann N; Brandt C; Zeuzem S; Hogardt M; Kempf VAJ; Müller M; Waidmann O; Reinheimer C
Liver Int; 2017 Oct; 37(10):1488-1496. PubMed ID: 28374901
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
[TBL] [Abstract][Full Text] [Related]
37. Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management.
Kaye KS; Pogue JM
Pharmacotherapy; 2015 Oct; 35(10):949-62. PubMed ID: 26497481
[TBL] [Abstract][Full Text] [Related]
38. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
39. Clinical and Microbiological Outcomes in Obese Patients Receiving Colistin for Carbapenem-Resistant Gram-Negative Bloodstream Infection.
Lam SW; Athans V
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235624
[TBL] [Abstract][Full Text] [Related]
40. Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features.
Leal HF; Azevedo J; Silva GEO; Amorim AML; de Roma LRC; Arraes ACP; Gouveia EL; Reis MG; Mendes AV; de Oliveira Silva M; Barberino MG; Martins IS; Reis JN
BMC Infect Dis; 2019 Jul; 19(1):609. PubMed ID: 31296179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
